1. Davies MJ, Aroda VR, Collins BS, et al. Management of hyperglycemiain type 2 diabetes, 2022. A consensus report by the American DiabetesAssociation (ADA) and the European Association for the Study ofDiabetes (EASD). Diab Care. 2022;45(11):2753-2786. doi: 10.2337/dci22-0034
2. Modzelewski R, Stefanowicz-Rutkowska MM, Matuszewski W, Bandurska-Stankiewicz EM. Gestational diabetes mellitus—recent literature review. JClin Med. 2022;11(19):5736.
3. Ogurtsova K, Guariguata L, Barengo NC, et al. IDF diabetes atlas: globalestimates of undiagnosed diabetes in adults for 2021. Diab Res Clin Pract.2022;183:109118.
4. Çiçek N. Kadın hastalıkları ve doğum bilgisi. Güneş Kitabevi: 2006.
5. Kjos SL, Buchanan TA. Gestational diabetes mellitus. New Engl J Med.1999;341(23):1749-1756.
6. Riskin-Mashiah S, Younes G, Damti A, Auslender R. First-trimesterfasting hyperglycemia and adverse pregnancy outcomes. Diab Care.2009;32(9):1639-1643.
7. Spencer K, Yu CK, Cowans NJ, Otigbah C, Nicolaides KH. Prediction ofpregnancy complications by first-trimester maternal serum PAPP-A andfree β-hCG and with second-trimester uterine artery Doppler. PrenatalDiagnosis. 2005;25(10):949-953.
8. Huang T, Hoffman B, Meschino W, Kingdom J, Okun N. Predictionof adverse pregnancy outcomes by combinations of first and secondtrimester biochemistry markers used in the routine prenatal screening ofDown syndrome. Prenatal Diagnosis. 2010;30(5):471-477.
9. Smith GC, Stenhouse EJ, Crossley JA, Aitken DA, Cameron AD, ConnorJM. Early pregnancy levels of pregnancy-associated plasma protein a andthe risk of intrauterine growth restriction, premature birth, preeclampsia,and stillbirth. J Clin Endocrinol Metab. 2002;87(4):1762-1767.
10. Dugoff L, Hobbins JC, Malone FD, et al. First-trimester maternalserum PAPP-A and free-beta subunit human chorionic gonadotropinconcentrations and nuchal translucency are associated with obstetriccomplications: a population-based screening study (the FASTER Trial).Am J Obstetr Gynecol. 2004;191(4):1446-1451.
11. Montanari L, Alfei A, Albonico G, et al. The impact of first-trimesterserum free β-human chorionic gonadotropin and pregnancy-associatedplasma protein A on the diagnosis of fetal growth restriction and small forgestational age infant. Fetal Diagn Therapy. 2009;25(1):130-135.
12. Mook-Kanamori DO, Steegers EA, Eilers PH, Raat H, Hofman A, JaddoeVW. Risk factors and outcomes associated with first-trimester fetal growthrestriction. JAMA. 2010;303(6):527-534.
13. Beneventi F, Simonetta M, Lovati E, et al. First trimester pregnancy-associated plasma protein-A in pregnancies complicated by subsequentgestational diabetes. Prenatal Diagn. 2011;31(6):523-528.
14. Ong CY, Liao AW, Spencer K, Munim S, Nicolaides KH. First trimestermaternal serum free β human chorionic gonadotrophin and pregnancyassociated plasma protein A as predictors of pregnancy complications.BJOG: Int J Obstetr Gynaecol. 2000;107(10):1265-1270.
15. Nese Kavak Z, Basgul A, Elter K, Uygur M, Gokaslan H. The efficacyof first-trimester PAPP-A and free βhCG levels for predicting adversepregnancy outcome. J Perinatal Med. 2006;34(2):145-148.
16. National Diabetes Data Group. Classification and diagnosis ofdiabetes mellitus and other categories of glucose intolerance. Diabetes.1979;28(12):1039-1057.
17. Krantz D, Goetzl L, Simpson JL, et al. Association of extreme first-trimester free human chorionic gonadotropin-β, pregnancy-associatedplasma protein A, and nuchal translucency with intrauterine growthrestriction and other adverse pregnancy outcomes. Am J Obstetr Gynecol.2004;191(4):1452-1458.
18. Ben-Haroush A, Yogev Y, Hod M. Epidemiology of gestational diabetesmellitus and its association with Type 2 diabetes. Diabetic Med.2004;21(2):103-113.
19. Xiao D, Chenhong W, Yanbin X, Lu Z. Gestational diabetes mellitus andfirst trimester pregnancy-associated plasma protein A: a case-controlstudy in a Chinese population. J Diab Invest. 2018;9(1):204-210.
20. Cui J, Li P, Chen X, et al. Study on the Relationship and predictive value offirst-trimester pregnancy-associated plasma protein-a, maternal factors,and biochemical parameters in gestational diabetes mellitus: a large case-control study in Southern China mothers. Diab Metab Syndr Obesity.2023;16:947-957.
21. Ren Z, Zhe D, Li Z, Sun XP, Yang K, Lin L. Study on the correlationand predictive value of serum pregnancy-associated plasma protein A,triglyceride and serum 25-hydroxyvitamin D levels with gestationaldiabetes mellitus. World J Clin Cases. 2020;8(5):864.
22. Ramezani S, Doulabi MA, Saqhafi H, Alipoor M. Prediction of gestationaldiabetes by measuring the levels of pregnancy associated plasmaprotein-A (PAPP-A) during gestation weeks 11-14. J Reproduc Infertil.2020;21(2):130.
23. Yanachkova VE, Staynova R, Bochev I, Kamenov Z. Potential roleof biochemical placentation markers—pregnancy associated plasmaprotein-A and human chorionic gonadotropin for early gestationaldiabetes screening—a pilot study. Ginekol Polska. 2022;93(5):405-409.
24. Visconti F, Quaresima P, Chiefari E, et al. First trimester combined test(FTCT) as a predictor of gestational diabetes mellitus. Int J Environ ResPublic Health. 2019;16(19):3654.